NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024Mary B. Daly, Susan Darlow, Banu Arun et al.|Journal of the National Comprehensive Cancer Network|2023Cited by 284
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan, Zeenat Diwan, Samir Gupta et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 91
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial CancerAndrea R. Hagemann, Kimberly K. Leslie|Cancers|2025Cited by 12